カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒトGnRHペプチド市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Human GnRH Peptide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7881）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7881
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：113
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒトGnRHペプチド市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のヒトGnRHペプチドの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のヒトGnRHペプチド市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ヒトGnRHペプチドの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ヒトGnRHペプチド市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・純度95%以下、純度95%-98%、純度98%以上

用途別セグメント
・子宮内膜症、子宮筋腫、人工生殖補助医療、前立腺がん、中枢性思春期早発症、その他

主要な市場プレーヤー
・Thermo Fisher Scientific、LSBio、Abcam、Merck Millipore、Kerafast、Abcepta、RayBiotech、Novus Biologicals、Ilex Life Sciences、Cloud - Clone、PEPTIDE INSTITUTE、MedChemExpress、Phoenix Pharmaceutical、AdooQ BioScience、IVDSHOW

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒトGnRHペプチド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒトGnRHペプチドメーカーの企業概要、2019年～2022年までのヒトGnRHペプチドの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒトGnRHペプチドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ヒトGnRHペプチドの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのヒトGnRHペプチドのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのヒトGnRHペプチド市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびヒトGnRHペプチドの産業チェーンを掲載しています。
・第14、15章では、ヒトGnRHペプチドの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ヒトGnRHペプチドの概要
– タイプ別分析（2018年vs2022年vs2029年）：純度95%以下、純度95%-98%、純度98%以上
– 用途別分析（2018年vs2022年vs2029年）：子宮内膜症、子宮筋腫、人工生殖補助医療、前立腺がん、中枢性思春期早発症、その他
– 世界のヒトGnRHペプチド市場規模・予測
– 世界のヒトGnRHペプチド生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Thermo Fisher Scientific、LSBio、Abcam、Merck Millipore、Kerafast、Abcepta、RayBiotech、Novus Biologicals、Ilex Life Sciences、Cloud – Clone、PEPTIDE INSTITUTE、MedChemExpress、Phoenix Pharmaceutical、AdooQ BioScience、IVDSHOW
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：純度95%以下、純度95%-98%、純度98%以上
・用途別分析2018年-2029年：子宮内膜症、子宮筋腫、人工生殖補助医療、前立腺がん、中枢性思春期早発症、その他
・ヒトGnRHペプチドの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒトGnRHペプチドのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒトGnRHペプチドのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒトGnRHペプチドの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒトGnRHペプチドの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Human GnRH Peptide
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human GnRH Peptide Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity Less Than 95%
1.3.3 Purity 95%-98%
1.3.4 Purity Greater Than 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Human GnRH Peptide Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Endometriosis
1.4.3 Uterine Fibroids
1.4.4 Artificial Assisted Reproduction
1.4.5 Prostate Cancer
1.4.6 Central Precocious Puberty
1.4.7 Others
1.5 Global Human GnRH Peptide Market Size & Forecast
1.5.1 Global Human GnRH Peptide Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human GnRH Peptide Sales Quantity (2018-2029)
1.5.3 Global Human GnRH Peptide Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Human GnRH Peptide Product and Services
2.1.4 Thermo Fisher Scientific Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Recent Developments/Updates
2.2 LSBio
2.2.1 LSBio Details
2.2.2 LSBio Major Business
2.2.3 LSBio Human GnRH Peptide Product and Services
2.2.4 LSBio Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 LSBio Recent Developments/Updates
2.3 Abcam
2.3.1 Abcam Details
2.3.2 Abcam Major Business
2.3.3 Abcam Human GnRH Peptide Product and Services
2.3.4 Abcam Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abcam Recent Developments/Updates
2.4 Merck Millipore
2.4.1 Merck Millipore Details
2.4.2 Merck Millipore Major Business
2.4.3 Merck Millipore Human GnRH Peptide Product and Services
2.4.4 Merck Millipore Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Millipore Recent Developments/Updates
2.5 Kerafast
2.5.1 Kerafast Details
2.5.2 Kerafast Major Business
2.5.3 Kerafast Human GnRH Peptide Product and Services
2.5.4 Kerafast Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kerafast Recent Developments/Updates
2.6 Abcepta
2.6.1 Abcepta Details
2.6.2 Abcepta Major Business
2.6.3 Abcepta Human GnRH Peptide Product and Services
2.6.4 Abcepta Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abcepta Recent Developments/Updates
2.7 RayBiotech
2.7.1 RayBiotech Details
2.7.2 RayBiotech Major Business
2.7.3 RayBiotech Human GnRH Peptide Product and Services
2.7.4 RayBiotech Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 RayBiotech Recent Developments/Updates
2.8 Novus Biologicals
2.8.1 Novus Biologicals Details
2.8.2 Novus Biologicals Major Business
2.8.3 Novus Biologicals Human GnRH Peptide Product and Services
2.8.4 Novus Biologicals Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Novus Biologicals Recent Developments/Updates
2.9 Ilex Life Sciences
2.9.1 Ilex Life Sciences Details
2.9.2 Ilex Life Sciences Major Business
2.9.3 Ilex Life Sciences Human GnRH Peptide Product and Services
2.9.4 Ilex Life Sciences Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ilex Life Sciences Recent Developments/Updates
2.10 Cloud – Clone
2.10.1 Cloud – Clone Details
2.10.2 Cloud – Clone Major Business
2.10.3 Cloud – Clone Human GnRH Peptide Product and Services
2.10.4 Cloud – Clone Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cloud – Clone Recent Developments/Updates
2.11 PEPTIDE INSTITUTE
2.11.1 PEPTIDE INSTITUTE Details
2.11.2 PEPTIDE INSTITUTE Major Business
2.11.3 PEPTIDE INSTITUTE Human GnRH Peptide Product and Services
2.11.4 PEPTIDE INSTITUTE Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PEPTIDE INSTITUTE Recent Developments/Updates
2.12 MedChemExpress
2.12.1 MedChemExpress Details
2.12.2 MedChemExpress Major Business
2.12.3 MedChemExpress Human GnRH Peptide Product and Services
2.12.4 MedChemExpress Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 MedChemExpress Recent Developments/Updates
2.13 Phoenix Pharmaceutical
2.13.1 Phoenix Pharmaceutical Details
2.13.2 Phoenix Pharmaceutical Major Business
2.13.3 Phoenix Pharmaceutical Human GnRH Peptide Product and Services
2.13.4 Phoenix Pharmaceutical Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Phoenix Pharmaceutical Recent Developments/Updates
2.14 AdooQ BioScience
2.14.1 AdooQ BioScience Details
2.14.2 AdooQ BioScience Major Business
2.14.3 AdooQ BioScience Human GnRH Peptide Product and Services
2.14.4 AdooQ BioScience Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 AdooQ BioScience Recent Developments/Updates
2.15 IVDSHOW
2.15.1 IVDSHOW Details
2.15.2 IVDSHOW Major Business
2.15.3 IVDSHOW Human GnRH Peptide Product and Services
2.15.4 IVDSHOW Human GnRH Peptide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 IVDSHOW Recent Developments/Updates
3 Competitive Environment: Human GnRH Peptide by Manufacturer
3.1 Global Human GnRH Peptide Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human GnRH Peptide Revenue by Manufacturer (2018-2023)
3.3 Global Human GnRH Peptide Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human GnRH Peptide by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human GnRH Peptide Manufacturer Market Share in 2022
3.4.2 Top 6 Human GnRH Peptide Manufacturer Market Share in 2022
3.5 Human GnRH Peptide Market: Overall Company Footprint Analysis
3.5.1 Human GnRH Peptide Market: Region Footprint
3.5.2 Human GnRH Peptide Market: Company Product Type Footprint
3.5.3 Human GnRH Peptide Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human GnRH Peptide Market Size by Region
4.1.1 Global Human GnRH Peptide Sales Quantity by Region (2018-2029)
4.1.2 Global Human GnRH Peptide Consumption Value by Region (2018-2029)
4.1.3 Global Human GnRH Peptide Average Price by Region (2018-2029)
4.2 North America Human GnRH Peptide Consumption Value (2018-2029)
4.3 Europe Human GnRH Peptide Consumption Value (2018-2029)
4.4 Asia-Pacific Human GnRH Peptide Consumption Value (2018-2029)
4.5 South America Human GnRH Peptide Consumption Value (2018-2029)
4.6 Middle East and Africa Human GnRH Peptide Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human GnRH Peptide Sales Quantity by Type (2018-2029)
5.2 Global Human GnRH Peptide Consumption Value by Type (2018-2029)
5.3 Global Human GnRH Peptide Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human GnRH Peptide Sales Quantity by Application (2018-2029)
6.2 Global Human GnRH Peptide Consumption Value by Application (2018-2029)
6.3 Global Human GnRH Peptide Average Price by Application (2018-2029)
7 North America
7.1 North America Human GnRH Peptide Sales Quantity by Type (2018-2029)
7.2 North America Human GnRH Peptide Sales Quantity by Application (2018-2029)
7.3 North America Human GnRH Peptide Market Size by Country
7.3.1 North America Human GnRH Peptide Sales Quantity by Country (2018-2029)
7.3.2 North America Human GnRH Peptide Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human GnRH Peptide Sales Quantity by Type (2018-2029)
8.2 Europe Human GnRH Peptide Sales Quantity by Application (2018-2029)
8.3 Europe Human GnRH Peptide Market Size by Country
8.3.1 Europe Human GnRH Peptide Sales Quantity by Country (2018-2029)
8.3.2 Europe Human GnRH Peptide Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human GnRH Peptide Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human GnRH Peptide Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human GnRH Peptide Market Size by Region
9.3.1 Asia-Pacific Human GnRH Peptide Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human GnRH Peptide Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human GnRH Peptide Sales Quantity by Type (2018-2029)
10.2 South America Human GnRH Peptide Sales Quantity by Application (2018-2029)
10.3 South America Human GnRH Peptide Market Size by Country
10.3.1 South America Human GnRH Peptide Sales Quantity by Country (2018-2029)
10.3.2 South America Human GnRH Peptide Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human GnRH Peptide Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human GnRH Peptide Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human GnRH Peptide Market Size by Country
11.3.1 Middle East & Africa Human GnRH Peptide Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human GnRH Peptide Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human GnRH Peptide Market Drivers
12.2 Human GnRH Peptide Market Restraints
12.3 Human GnRH Peptide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human GnRH Peptide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human GnRH Peptide
13.3 Human GnRH Peptide Production Process
13.4 Human GnRH Peptide Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human GnRH Peptide Typical Distributors
14.3 Human GnRH Peptide Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Human GnRH Peptide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human GnRH Peptide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Scientific Major Business
Table 5. Thermo Fisher Scientific Human GnRH Peptide Product and Services
Table 6. Thermo Fisher Scientific Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Thermo Fisher Scientific Recent Developments/Updates
Table 8. LSBio Basic Information, Manufacturing Base and Competitors
Table 9. LSBio Major Business
Table 10. LSBio Human GnRH Peptide Product and Services
Table 11. LSBio Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. LSBio Recent Developments/Updates
Table 13. Abcam Basic Information, Manufacturing Base and Competitors
Table 14. Abcam Major Business
Table 15. Abcam Human GnRH Peptide Product and Services
Table 16. Abcam Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abcam Recent Developments/Updates
Table 18. Merck Millipore Basic Information, Manufacturing Base and Competitors
Table 19. Merck Millipore Major Business
Table 20. Merck Millipore Human GnRH Peptide Product and Services
Table 21. Merck Millipore Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Millipore Recent Developments/Updates
Table 23. Kerafast Basic Information, Manufacturing Base and Competitors
Table 24. Kerafast Major Business
Table 25. Kerafast Human GnRH Peptide Product and Services
Table 26. Kerafast Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Kerafast Recent Developments/Updates
Table 28. Abcepta Basic Information, Manufacturing Base and Competitors
Table 29. Abcepta Major Business
Table 30. Abcepta Human GnRH Peptide Product and Services
Table 31. Abcepta Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Abcepta Recent Developments/Updates
Table 33. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 34. RayBiotech Major Business
Table 35. RayBiotech Human GnRH Peptide Product and Services
Table 36. RayBiotech Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. RayBiotech Recent Developments/Updates
Table 38. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 39. Novus Biologicals Major Business
Table 40. Novus Biologicals Human GnRH Peptide Product and Services
Table 41. Novus Biologicals Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Novus Biologicals Recent Developments/Updates
Table 43. Ilex Life Sciences Basic Information, Manufacturing Base and Competitors
Table 44. Ilex Life Sciences Major Business
Table 45. Ilex Life Sciences Human GnRH Peptide Product and Services
Table 46. Ilex Life Sciences Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Ilex Life Sciences Recent Developments/Updates
Table 48. Cloud - Clone Basic Information, Manufacturing Base and Competitors
Table 49. Cloud - Clone Major Business
Table 50. Cloud - Clone Human GnRH Peptide Product and Services
Table 51. Cloud - Clone Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Cloud - Clone Recent Developments/Updates
Table 53. PEPTIDE INSTITUTE Basic Information, Manufacturing Base and Competitors
Table 54. PEPTIDE INSTITUTE Major Business
Table 55. PEPTIDE INSTITUTE Human GnRH Peptide Product and Services
Table 56. PEPTIDE INSTITUTE Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. PEPTIDE INSTITUTE Recent Developments/Updates
Table 58. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 59. MedChemExpress Major Business
Table 60. MedChemExpress Human GnRH Peptide Product and Services
Table 61. MedChemExpress Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. MedChemExpress Recent Developments/Updates
Table 63. Phoenix Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Phoenix Pharmaceutical Major Business
Table 65. Phoenix Pharmaceutical Human GnRH Peptide Product and Services
Table 66. Phoenix Pharmaceutical Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Phoenix Pharmaceutical Recent Developments/Updates
Table 68. AdooQ BioScience Basic Information, Manufacturing Base and Competitors
Table 69. AdooQ BioScience Major Business
Table 70. AdooQ BioScience Human GnRH Peptide Product and Services
Table 71. AdooQ BioScience Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. AdooQ BioScience Recent Developments/Updates
Table 73. IVDSHOW Basic Information, Manufacturing Base and Competitors
Table 74. IVDSHOW Major Business
Table 75. IVDSHOW Human GnRH Peptide Product and Services
Table 76. IVDSHOW Human GnRH Peptide Sales Quantity (Kilogram), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. IVDSHOW Recent Developments/Updates
Table 78. Global Human GnRH Peptide Sales Quantity by Manufacturer (2018-2023) & (Kilogram)
Table 79. Global Human GnRH Peptide Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Human GnRH Peptide Average Price by Manufacturer (2018-2023) & (US$/mg)
Table 81. Market Position of Manufacturers in Human GnRH Peptide, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Human GnRH Peptide Production Site of Key Manufacturer
Table 83. Human GnRH Peptide Market: Company Product Type Footprint
Table 84. Human GnRH Peptide Market: Company Product Application Footprint
Table 85. Human GnRH Peptide New Market Entrants and Barriers to Market Entry
Table 86. Human GnRH Peptide Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Human GnRH Peptide Sales Quantity by Region (2018-2023) & (Kilogram)
Table 88. Global Human GnRH Peptide Sales Quantity by Region (2024-2029) & (Kilogram)
Table 89. Global Human GnRH Peptide Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Human GnRH Peptide Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Human GnRH Peptide Average Price by Region (2018-2023) & (US$/mg)
Table 92. Global Human GnRH Peptide Average Price by Region (2024-2029) & (US$/mg)
Table 93. Global Human GnRH Peptide Sales Quantity by Type (2018-2023) & (Kilogram)
Table 94. Global Human GnRH Peptide Sales Quantity by Type (2024-2029) & (Kilogram)
Table 95. Global Human GnRH Peptide Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Human GnRH Peptide Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Human GnRH Peptide Average Price by Type (2018-2023) & (US$/mg)
Table 98. Global Human GnRH Peptide Average Price by Type (2024-2029) & (US$/mg)
Table 99. Global Human GnRH Peptide Sales Quantity by Application (2018-2023) & (Kilogram)
Table 100. Global Human GnRH Peptide Sales Quantity by Application (2024-2029) & (Kilogram)
Table 101. Global Human GnRH Peptide Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Human GnRH Peptide Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Human GnRH Peptide Average Price by Application (2018-2023) & (US$/mg)
Table 104. Global Human GnRH Peptide Average Price by Application (2024-2029) & (US$/mg)
Table 105. North America Human GnRH Peptide Sales Quantity by Type (2018-2023) & (Kilogram)
Table 106. North America Human GnRH Peptide Sales Quantity by Type (2024-2029) & (Kilogram)
Table 107. North America Human GnRH Peptide Sales Quantity by Application (2018-2023) & (Kilogram)
Table 108. North America Human GnRH Peptide Sales Quantity by Application (2024-2029) & (Kilogram)
Table 109. North America Human GnRH Peptide Sales Quantity by Country (2018-2023) & (Kilogram)
Table 110. North America Human GnRH Peptide Sales Quantity by Country (2024-2029) & (Kilogram)
Table 111. North America Human GnRH Peptide Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Human GnRH Peptide Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Human GnRH Peptide Sales Quantity by Type (2018-2023) & (Kilogram)
Table 114. Europe Human GnRH Peptide Sales Quantity by Type (2024-2029) & (Kilogram)
Table 115. Europe Human GnRH Peptide Sales Quantity by Application (2018-2023) & (Kilogram)
Table 116. Europe Human GnRH Peptide Sales Quantity by Application (2024-2029) & (Kilogram)
Table 117. Europe Human GnRH Peptide Sales Quantity by Country (2018-2023) & (Kilogram)
Table 118. Europe Human GnRH Peptide Sales Quantity by Country (2024-2029) & (Kilogram)
Table 119. Europe Human GnRH Peptide Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Human GnRH Peptide Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Human GnRH Peptide Sales Quantity by Type (2018-2023) & (Kilogram)
Table 122. Asia-Pacific Human GnRH Peptide Sales Quantity by Type (2024-2029) & (Kilogram)
Table 123. Asia-Pacific Human GnRH Peptide Sales Quantity by Application (2018-2023) & (Kilogram)
Table 124. Asia-Pacific Human GnRH Peptide Sales Quantity by Application (2024-2029) & (Kilogram)
Table 125. Asia-Pacific Human GnRH Peptide Sales Quantity by Region (2018-2023) & (Kilogram)
Table 126. Asia-Pacific Human GnRH Peptide Sales Quantity by Region (2024-2029) & (Kilogram)
Table 127. Asia-Pacific Human GnRH Peptide Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Human GnRH Peptide Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Human GnRH Peptide Sales Quantity by Type (2018-2023) & (Kilogram)
Table 130. South America Human GnRH Peptide Sales Quantity by Type (2024-2029) & (Kilogram)
Table 131. South America Human GnRH Peptide Sales Quantity by Application (2018-2023) & (Kilogram)
Table 132. South America Human GnRH Peptide Sales Quantity by Application (2024-2029) & (Kilogram)
Table 133. South America Human GnRH Peptide Sales Quantity by Country (2018-2023) & (Kilogram)
Table 134. South America Human GnRH Peptide Sales Quantity by Country (2024-2029) & (Kilogram)
Table 135. South America Human GnRH Peptide Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Human GnRH Peptide Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Human GnRH Peptide Sales Quantity by Type (2018-2023) & (Kilogram)
Table 138. Middle East & Africa Human GnRH Peptide Sales Quantity by Type (2024-2029) & (Kilogram)
Table 139. Middle East & Africa Human GnRH Peptide Sales Quantity by Application (2018-2023) & (Kilogram)
Table 140. Middle East & Africa Human GnRH Peptide Sales Quantity by Application (2024-2029) & (Kilogram)
Table 141. Middle East & Africa Human GnRH Peptide Sales Quantity by Region (2018-2023) & (Kilogram)
Table 142. Middle East & Africa Human GnRH Peptide Sales Quantity by Region (2024-2029) & (Kilogram)
Table 143. Middle East & Africa Human GnRH Peptide Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Human GnRH Peptide Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Human GnRH Peptide Raw Material
Table 146. Key Manufacturers of Human GnRH Peptide Raw Materials
Table 147. Human GnRH Peptide Typical Distributors
Table 148. Human GnRH Peptide Typical Customers
List of Figures
Figure 1. Human GnRH Peptide Picture
Figure 2. Global Human GnRH Peptide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human GnRH Peptide Consumption Value Market Share by Type in 2022
Figure 4. Purity Less Than 95% Examples
Figure 5. Purity 95%-98% Examples
Figure 6. Purity Greater Than 98% Examples
Figure 7. Global Human GnRH Peptide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Human GnRH Peptide Consumption Value Market Share by Application in 2022
Figure 9. Endometriosis Examples
Figure 10. Uterine Fibroids Examples
Figure 11. Artificial Assisted Reproduction Examples
Figure 12. Prostate Cancer Examples
Figure 13. Central Precocious Puberty Examples
Figure 14. Others Examples
Figure 15. Global Human GnRH Peptide Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Human GnRH Peptide Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Human GnRH Peptide Sales Quantity (2018-2029) & (Kilogram)
Figure 18. Global Human GnRH Peptide Average Price (2018-2029) & (US$/mg)
Figure 19. Global Human GnRH Peptide Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Human GnRH Peptide Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Human GnRH Peptide by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Human GnRH Peptide Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Human GnRH Peptide Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Human GnRH Peptide Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Human GnRH Peptide Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Human GnRH Peptide Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Human GnRH Peptide Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Human GnRH Peptide Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Human GnRH Peptide Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Human GnRH Peptide Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Human GnRH Peptide Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Human GnRH Peptide Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Human GnRH Peptide Average Price by Type (2018-2029) & (US$/mg)
Figure 34. Global Human GnRH Peptide Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Human GnRH Peptide Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Human GnRH Peptide Average Price by Application (2018-2029) & (US$/mg)
Figure 37. North America Human GnRH Peptide Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Human GnRH Peptide Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Human GnRH Peptide Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Human GnRH Peptide Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Human GnRH Peptide Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Human GnRH Peptide Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Human GnRH Peptide Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Human GnRH Peptide Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Human GnRH Peptide Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Human GnRH Peptide Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Human GnRH Peptide Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Human GnRH Peptide Consumption Value Market Share by Region (2018-2029)
Figure 57. China Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Human GnRH Peptide Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Human GnRH Peptide Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Human GnRH Peptide Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Human GnRH Peptide Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Human GnRH Peptide Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Human GnRH Peptide Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Human GnRH Peptide Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Human GnRH Peptide Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Human GnRH Peptide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Human GnRH Peptide Market Drivers
Figure 78. Human GnRH Peptide Market Restraints
Figure 79. Human GnRH Peptide Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Human GnRH Peptide in 2022
Figure 82. Manufacturing Process Analysis of Human GnRH Peptide
Figure 83. Human GnRH Peptide Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の抗GnRH抗体市場2023年：企業・地域・タイプ・用途別分析
  • 世界の人間用耳鏡ヘッド市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト・フィブリン糊市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒトアルブミン注射市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト精子細胞凍結保存液市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7881 )"世界のヒトGnRHペプチド市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Human GnRH Peptide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。